Greggi, Stefano
 Distribuzione geografica
Continente #
AS - Asia 284
NA - Nord America 142
EU - Europa 121
SA - Sud America 12
OC - Oceania 2
Totale 561
Nazione #
CN - Cina 240
US - Stati Uniti d'America 141
DE - Germania 31
SE - Svezia 24
SG - Singapore 23
IT - Italia 15
BR - Brasile 11
FR - Francia 11
UA - Ucraina 10
IE - Irlanda 9
ID - Indonesia 6
RU - Federazione Russa 5
TR - Turchia 5
GB - Regno Unito 4
FI - Finlandia 3
JP - Giappone 3
NL - Olanda 3
AT - Austria 2
AU - Australia 2
IN - India 2
BE - Belgio 1
CA - Canada 1
CO - Colombia 1
ES - Italia 1
HU - Ungheria 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
RO - Romania 1
SA - Arabia Saudita 1
VN - Vietnam 1
Totale 561
Città #
Hangzhou 168
Beijing 44
Chandler 39
Singapore 16
Nanjing 12
Dublin 9
Jacksonville 7
New York 7
Ashburn 6
Jakarta 6
San Mateo 6
Cattolica 5
Wilmington 5
Boston 4
Dearborn 4
Frankfurt am Main 3
Guangzhou 3
London 3
Los Angeles 3
Nanchang 3
Princeton 3
Florence 2
Houston 2
Izmir 2
Kunming 2
Lawrence 2
Milan 2
Moscow 2
Okayama 2
Redwood City 2
Rome 2
Vienna 2
Amsterdam 1
Andrelândia 1
Ann Arbor 1
Astana 1
Belo Horizonte 1
Betim 1
Bishkek 1
Bogotá 1
Bologna 1
Bremen 1
Brisbane 1
Brussels 1
Cachoeira do Sul 1
Chapadão do Sul 1
Düsseldorf 1
Hanoi 1
Helsinki 1
Jiaxing 1
Jinan 1
Lanzhou 1
Leawood 1
Madrid 1
Maringá 1
Mountain View 1
Munich 1
New Orleans 1
Newark 1
Norwalk 1
Oggiono 1
Philadelphia 1
Poá 1
Presidente Prudente 1
Riyadh 1
Roubaix 1
Shenyang 1
Simi Valley 1
Stockholm 1
Sumaré 1
Sydney 1
São Bernardo do Campo 1
Tettnang 1
Tianjin 1
Trieste 1
University Park 1
Valinhos 1
Vientiane 1
Viroflay 1
Wenzhou 1
Woodbridge 1
Wuhan 1
Totale 428
Nome #
Carboplatin plus paclitaxel versus carboplatin plus pegylated liposomal doxorubicin as first-line treatment for patients with ovarian cancer: the MITO-2 randomized phase III trial 322
Surgical and medical treatment of clear cell ovarian cancer: results from the multicenter Italian Trials in Ovarian Cancer (MITO) 9 retrospective study 71
Feasibility and outcome of interval debulking surgery (IDS) after carboplatin-paclitaxel-bevacizumab (CPB): A subgroup analysis of the MITO-16A-MaNGO OV2A phase 4 trial 61
1st Evidence-based Italian consensus conference on cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinosis from ovarian cancer 58
Tertiary cytoreductive surgery in recurrent epithelial ovarian cancer: A multicentre MITO retrospective study 54
Totale 566
Categoria #
all - tutte 2.099
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.099


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202019 0 0 0 0 0 0 0 0 0 0 0 19
2020/202143 26 2 1 1 2 0 5 0 2 1 3 0
2021/202228 2 1 0 2 2 0 0 10 0 1 4 6
2022/202381 10 11 7 7 10 13 0 7 12 1 3 0
2023/202441 3 16 0 2 1 6 4 0 0 0 4 5
2024/202578 1 2 6 2 4 4 2 9 17 7 11 13
Totale 566